Literature DB >> 12926048

Expression of cytokines and receptors in normal, immortalized, and malignant ovarian epithelial cell lines.

Christina A Bandera1, Hing Wo Tsui, Samuel C Mok, Florence W Tsui.   

Abstract

BACKGROUND: Ovarian carcinoma originates from the epithelial cells on the surface of the ovary. This study evaluates cytokine production by these cells.
MATERIALS AND METHODS: Normal human ovary surface epithelial cells (HOSE cells), immortalized HOSE cells and ovarian cancer cells were used for the study of cytokines.
RESULTS: Eight of 14 cytokines were increased in > or = 3 ovarian cancer cell lines compared with normal HOSE cells. Three cytokines were increased 5-fold in the immortalized HOSE cell line and in multiple ovarian cancer cell lines. Cytokine receptor expression revealed that 7 of 8 ovarian cancer cell lines had > or = 1 autocrine loop. Anti-EGFR antibody failed to inhibit growth of ovarian cancer cells which expressed multiple cytokine receptors.
CONCLUSION: Ovarian cancer cells produce more cytokines than normal HOSE cells. Immortalized HOSE cells display a cytokine profile similar to the cancer cells. Finally, multiple autocrine loops in ovarian cancer may limit the therapeutic usefulness of single cytokine receptor blockade.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926048

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.

Authors:  Katia Meirelles; Leo Andrew Benedict; David Dombkowski; David Pepin; Frederic I Preffer; Jose Teixeira; Pradeep Singh Tanwar; Robert H Young; David T MacLaughlin; Patricia K Donahoe; Xiaolong Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-27       Impact factor: 11.205

2.  Epidermal growth factor receptor blockers for the treatment of ovarian cancer.

Authors:  Krishnayan Haldar; Kezia Gaitskell; Andrew Bryant; Heather O Dickinson; Shibani Nicum; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2009

3.  Epidermal growth factor receptor blockers for the treatment of ovarian cancer.

Authors:  Jo Morrison; Clemens Thoma; Richard J Goodall; Thomas J Lyons; Kezia Gaitskell; Alison J Wiggans; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2018-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.